A new minimally-invasive method for microinjection into the mouse spinal dorsal horn

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kohro, Yuta ^a   Sakaguchi, Emi ^a   Tashima, Ryoichi ^a   Tozaki Saitoh, Hidetoshi ^a   Okano, Hideyuki ^b   Inoue, Kazuhide ^a   Tsuda, Makoto ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN; STAT3 PROTEIN, MOUSE;

ANIMAL; ASTROCYTE; DEPENDOPARVOVIRUS; FEMALE; GENE TRANSFER; GENETICS; MALE; METABOLISM; MICROINJECTION; MOUSE; PROCEDURES; SPINAL CORD DORSAL HORN; TRANSGENE;

ANIMALS; ASTROCYTES; DEPENDOVIRUS; FEMALE; GENE TRANSFER TECHNIQUES; MALE; MICE; MICROINJECTIONS; SPINAL CORD DORSAL HORN; STAT3 TRANSCRIPTION FACTOR; TRANSGENES;

EID: 84942106513     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14306     Document Type: Article

References (51)

1. Braz, J., Solorzano, C., Wang, X. and Basbaum, A. I. Transmitting pain and itch messages: a contemporary view of the spinal cord circuits that generate gate control. Neuron 82, 522-536 (2014).
2. Todd, A. J. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 11, 823-836 (2010).
3. Abraira, V. E. and Ginty, D. D. The sensory neurons of touch. Neuron 79, 618-639 (2013).
4. Prescott, S. A., Ma, Q. and De Koninck, Y. Normal and abnormal coding of somatosensory stimuli causing pain. Nat Neurosci 17, 183-191 (2014).
5. Scholz, J. and Woolf, C. J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10, 1361-1368 (2007).
6. Ji, R. R., Berta, T. and Nedergaard, M. Glia and pain: is chronic pain a gliopathy? Pain 154 Suppl 1, S10-28 (2013).
7. Bourdenx, M., Dutheil, N., Bezard, E. and Dehay, B. Systemic gene delivery to the central nervous system using Adeno-associated virus. Front Mol Neurosci 7, 50 (2014).
8. Merienne, N., Le Douce, J., Faivre, E., Deglon, N. and Bonvento, G. Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors. Front Cell Neurosci 7, 106 (2013).
9. Kato, S. and Kobayashi, K. Dissecting circuit mechanisms by genetic manipulation of specific neural pathways. Rev Neurosci 24, 1-8 (2013).
10. Lu, Y. et al. TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-alpha and IL-1beta signaling. Pain 155, 2618-2629 (2014).
11. Zhang, Z. J., Cao, D. L., Zhang, X., Ji, R. R. and Gao, Y. J. Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain 154, 2185-2197 (2013).
12. Tappe, A. et al. Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nat Med 12, 677-681 (2006).
13. Tappe-Theodor, A. et al. A molecular basis of analgesic tolerance to cannabinoids. J Neurosci 27, 4165-4177 (2007).
14. Simonetti, M. et al. Nuclear calcium signaling in spinal neurons drives a genomic program required for persistent inflammatory pain. Neuron 77, 43-57 (2013).
15. Meunier, A., Mauborgne, A., Masson, J., Mallet, J. and Pohl, M. Lentiviral-mediated targeted transgene expression in dorsal spinal cord glia: tool for the study of glial cell implication in mechanisms underlying chronic pain development. J Neurosci Methods 167, 148-159 (2008).
16. Dominguez, E., Mauborgne, A., Mallet, J., Desclaux, M. and Pohl, M. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J Neurosci 30, 5754-5766 (2010).
17. Kawasaki, Y., Zhang, L., Cheng, J. K. and Ji, R. R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28, 5189-5194 (2008).
18. Gruber-Schoffnegger, D. et al. Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I by TNF-alpha and IL-1beta is mediated by glial cells. J Neurosci 33, 6540-6551 (2013).
19. Zhang, L. et al. TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. Pain 152, 419-427 (2011).
20. Parpura, V. et al. Glial cells in (patho)physiology. J Neurochem 121, 4-27 (2012).
21. Sofroniew, M. V. and Vinters, H. V. Astrocytes: biology and pathology. Acta Neuropathol 119, 7-35 (2010).
22. Verkhratsky, A. et al. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 4; doi: 10.1042/an20120010 (2012).
23. Ortinski, P. I. et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13, 584-591 (2010).
24. Shigetomi, E. et al. Imaging calcium microdomains within entire astrocyte territories and endfeet with GCaMPs expressed using adeno-associated viruses. J Gen Physiol 141, 633-647 (2013).
25. Tong, X. et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat Neurosci 17, 694-703 (2014).
26. Haustein, M. D. et al. Conditions and constraints for astrocyte calcium signaling in the hippocampal mossy fiber pathway. Neuron 82, 413-429 (2014).
27. Xie, Y., Wang, T., Sun, G. Y. and Ding, S. Specific disruption of astrocytic Ca2+ signaling pathway in vivo by adeno-associated viral transduction. Neuroscience 170, 992-1003 (2010).
28. Tsuda, M. et al. JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain 134, 1127-1139 (2011).
29. Dominguez, E., Rivat, C., Pommier, B., Mauborgne, A. and Pohl, M. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J Neurochem 107, 50-60 (2008).
30. Bonni, A. et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278, 477-483 (1997).
31. Herrmann, J. E. et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28, 7231-7243 (2008).
32. Wanner, I. B. et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci 33, 12870-12886 (2013).
33. Bromberg, J. F. et al. Stat3 as an oncogene. Cell 98, 295-303 (1999).
34. Chen, G. et al. Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice. Brain 137, 2193-2209 (2014).
35. Gao, Y. J. et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29, 4096-4108 (2009).
36. Kawasaki, Y. et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14, 331-336 (2008).
37. Zhuang, Z. Y., Gerner, P., Woolf, C. J. and Ji, R. R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114, 149-159 (2005).
38. Katsura, H. et al. Transforming growth factor-activated kinase 1 induced in spinal astrocytes contributes to mechanical hypersensitivity after nerve injury. Glia 56, 723-733 (2008).
39. Imai, S. et al. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain. Brain 136, 828-843 (2013).
40. Gradinaru, V., Mogri, M., Thompson, K. R., Henderson, J. M. and Deisseroth, K. Optical deconstruction of parkinsonian neural circuitry. Science 324, 354-359 (2009).
41. Gourine, A. V. et al. Astrocytes control breathing through pH-dependent release of ATP. Science 329, 571-575 (2010).
42. Bull, C. et al. Rat nucleus accumbens core astrocytes modulate reward and the motivation to self-administer ethanol after abstinence. Neuropsychopharmacology 39, 2835-2845 (2014).
43. Takeda, K. et al. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 161, 4652-4660 (1998).
44. Lee, Y., Messing, A., Su, M. and Brenner, M. GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia 56, 481-493 (2008).
45. Vandenberghe, L. H. et al. Efficient serotype-dependent release of functional vector into the culture medium during adenoassociated virus manufacturing. Hum Gene Ther 21, 1251-1257 (2010).
46. Lock, M. et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther 21, 1259-1271 (2010).
47. Ayuso, E. et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther 17, 503-510 (2010).
48. Hylden, J. L. and Wilcox, G. L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67, 313-316 (1980).
49. Kim, S. H. and Chung, J. M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355-363 (1992).
50. Masuda, T. et al. Transcription factor IRF5 drives P2X4R+ -reactive microglia gating neuropathic pain. Nat Commun 5, 3771 (2014).
51. Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M. and Yaksh, T. L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53, 55-63 (1994).